Paul J. Deziel

Emergence of drug‐resistant cytomegalovirus in the era of valganciclovir prophylaxis: therapeutic implications and outcomes

Albert Eid, Supha K. Arthurs, Paul J. Deziel et al. · Clinical Transplantation · 2007 · 174 citations

Life Sciences, Infectious Diseases, Microbiology +17

Fluoride Excess and Periostitis in Transplant Patients Receiving Long-Term Voriconazole Therapy

Robert A. Wermers, Katherine M. Cooper, Raymund R. Razonable et al. · Clinical Infectious Diseases · 2011 · 128 citations

Medicine, Nephrology, Pharmacology +16

Clinical Predictors of Relapse after Treatment of Primary Gastrointestinal Cytomegalovirus Disease in Solid Organ Transplant Recipients

A.J. Eid, Supha K. Arthurs, Paul J. Deziel et al. · American Journal of Transplantation · 2009 · 114 citations

Life Sciences, Immunology, Infectious Diseases +15

The impact of invasive fungal diseases on survival after lung transplantation

Supha K. Arthurs, Albert Eid, Paul J. Deziel et al. · Clinical Transplantation · 2009 · 69 citations

Medicine, Infectious Diseases, Surgery +17

Deficiency of cytomegalovirus (CMV)‐specific CD8+ T cells in patients presenting with late‐onset CMV disease several years after transplantation

Nathan W. Cummins, Paul J. Deziel, Roshini S. Abraham et al. · Transplant Infectious Disease · 2008 · 58 citations

Life Sciences, Immunology, Infectious Diseases +17